Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging

Ming Qiang Zheng, Duan Zhi Yin, Lan Zhang, Bei Lei, Deng Feng Cheng, Han Cheng Cai, Yan Jiang Han, Ming Xing Wu, Hong Zhang, Jing Wang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Aim: To evaluate whether the newly-synthesized positron emission tomography (PET) tracer, [18F]2-(4′-(methylamino)phenyl)-6-fluoroethoxy- benzothiazole ([18F] O-FEt-PIB), could bind to β-amyloid aggregates in a rat model of Alzheimer's disease (AD) using micro-PET. Method: [18F]O-FEt-PIB was synthesized and purified by radio HPLC. PET imaging was performed with a R4 rodent model scanner in 3 model and 3 control rats. Dynamic PET scans were performed for 40 min in each rat following an injection of approximately 37 MBq of [18F]O-FEt-PIB. Static scans were also performed for 15 min in each rat. PET data were reconstructed by a maximum posteriori probability algorithm. On the coronal PET images, regions of interest were respectively placed on the cortex, hemicerebrum [including the hippocampus and thalamus (HT)], and were guided by a 3-D digital map of the rat brain or the brain images of [18F]2-Deoxy-2-fluoro-JD-glucose ([ 18F]FDG) in normal rats. Time-activity curves (TAC) were obtained for the cerebrum and cerebellum. The activity difference value (ADV) between 2 hemicerebrums was also calculated. Results: The TAC for [18F]O-FEt- PIB in the cerebrum or cerebellum peaked early (at approximately 2 min), but washed out a little slowly. In the dynamic and static micro-PET images, increased radioactivity was found in the area of the right HT in the model rats where infused with β-amyloid (1-40). No distinct difference of radioactivity was found between the right and left HT areas in the control rats. The ADV(HT) was approximately 14.6% in the AD model rats and approximately 4 times greater than that of the control rats (3.9%). Conclusion: To our knowledge, this study is the first to evaluate a small molecular PET probe for the p-amyloid deposits in vivo using micro-PET imaging in an AD-injected rat model. The suitable biological characters showed that the tracer had potential to be developed as a probe for detecting β-amyloid plaques in AD.

Original languageEnglish (US)
Pages (from-to)548-554
Number of pages7
JournalActa Pharmacologica Sinica
Volume29
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

Positron emission tomography
Positron-Emission Tomography
Rats
Alzheimer Disease
Imaging techniques
Rat control
Amyloid
Thalamus
Hippocampus
Radioactivity
Amyloid Plaques
Cerebrum
Brain
Cerebellum
Radio
Deposits
Rodentia
Glucose
High Pressure Liquid Chromatography

Keywords

  • [F]O-FEt-PIB
  • Alzheimer's disease
  • Micro-positron emission tomography

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmacology
  • Pharmacology (medical)

Cite this

Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging. / Zheng, Ming Qiang; Yin, Duan Zhi; Zhang, Lan; Lei, Bei; Cheng, Deng Feng; Cai, Han Cheng; Han, Yan Jiang; Wu, Ming Xing; Zhang, Hong; Wang, Jing.

In: Acta Pharmacologica Sinica, Vol. 29, No. 5, 05.2008, p. 548-554.

Research output: Contribution to journalArticle

Zheng, MQ, Yin, DZ, Zhang, L, Lei, B, Cheng, DF, Cai, HC, Han, YJ, Wu, MX, Zhang, H & Wang, J 2008, 'Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging', Acta Pharmacologica Sinica, vol. 29, no. 5, pp. 548-554. https://doi.org/10.1111/j.1745-7254.2008.00785.x
Zheng, Ming Qiang ; Yin, Duan Zhi ; Zhang, Lan ; Lei, Bei ; Cheng, Deng Feng ; Cai, Han Cheng ; Han, Yan Jiang ; Wu, Ming Xing ; Zhang, Hong ; Wang, Jing. / Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging. In: Acta Pharmacologica Sinica. 2008 ; Vol. 29, No. 5. pp. 548-554.
@article{781df7e3464f48fbb0d8833807328d71,
title = "Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging",
abstract = "Aim: To evaluate whether the newly-synthesized positron emission tomography (PET) tracer, [18F]2-(4′-(methylamino)phenyl)-6-fluoroethoxy- benzothiazole ([18F] O-FEt-PIB), could bind to β-amyloid aggregates in a rat model of Alzheimer's disease (AD) using micro-PET. Method: [18F]O-FEt-PIB was synthesized and purified by radio HPLC. PET imaging was performed with a R4 rodent model scanner in 3 model and 3 control rats. Dynamic PET scans were performed for 40 min in each rat following an injection of approximately 37 MBq of [18F]O-FEt-PIB. Static scans were also performed for 15 min in each rat. PET data were reconstructed by a maximum posteriori probability algorithm. On the coronal PET images, regions of interest were respectively placed on the cortex, hemicerebrum [including the hippocampus and thalamus (HT)], and were guided by a 3-D digital map of the rat brain or the brain images of [18F]2-Deoxy-2-fluoro-JD-glucose ([ 18F]FDG) in normal rats. Time-activity curves (TAC) were obtained for the cerebrum and cerebellum. The activity difference value (ADV) between 2 hemicerebrums was also calculated. Results: The TAC for [18F]O-FEt- PIB in the cerebrum or cerebellum peaked early (at approximately 2 min), but washed out a little slowly. In the dynamic and static micro-PET images, increased radioactivity was found in the area of the right HT in the model rats where infused with β-amyloid (1-40). No distinct difference of radioactivity was found between the right and left HT areas in the control rats. The ADV(HT) was approximately 14.6{\%} in the AD model rats and approximately 4 times greater than that of the control rats (3.9{\%}). Conclusion: To our knowledge, this study is the first to evaluate a small molecular PET probe for the p-amyloid deposits in vivo using micro-PET imaging in an AD-injected rat model. The suitable biological characters showed that the tracer had potential to be developed as a probe for detecting β-amyloid plaques in AD.",
keywords = "[F]O-FEt-PIB, Alzheimer's disease, Micro-positron emission tomography",
author = "Zheng, {Ming Qiang} and Yin, {Duan Zhi} and Lan Zhang and Bei Lei and Cheng, {Deng Feng} and Cai, {Han Cheng} and Han, {Yan Jiang} and Wu, {Ming Xing} and Hong Zhang and Jing Wang",
year = "2008",
month = "5",
doi = "10.1111/j.1745-7254.2008.00785.x",
language = "English (US)",
volume = "29",
pages = "548--554",
journal = "Zhongguo yao li xue bao = Acta pharmacologica Sinica",
issn = "1671-4083",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging

AU - Zheng, Ming Qiang

AU - Yin, Duan Zhi

AU - Zhang, Lan

AU - Lei, Bei

AU - Cheng, Deng Feng

AU - Cai, Han Cheng

AU - Han, Yan Jiang

AU - Wu, Ming Xing

AU - Zhang, Hong

AU - Wang, Jing

PY - 2008/5

Y1 - 2008/5

N2 - Aim: To evaluate whether the newly-synthesized positron emission tomography (PET) tracer, [18F]2-(4′-(methylamino)phenyl)-6-fluoroethoxy- benzothiazole ([18F] O-FEt-PIB), could bind to β-amyloid aggregates in a rat model of Alzheimer's disease (AD) using micro-PET. Method: [18F]O-FEt-PIB was synthesized and purified by radio HPLC. PET imaging was performed with a R4 rodent model scanner in 3 model and 3 control rats. Dynamic PET scans were performed for 40 min in each rat following an injection of approximately 37 MBq of [18F]O-FEt-PIB. Static scans were also performed for 15 min in each rat. PET data were reconstructed by a maximum posteriori probability algorithm. On the coronal PET images, regions of interest were respectively placed on the cortex, hemicerebrum [including the hippocampus and thalamus (HT)], and were guided by a 3-D digital map of the rat brain or the brain images of [18F]2-Deoxy-2-fluoro-JD-glucose ([ 18F]FDG) in normal rats. Time-activity curves (TAC) were obtained for the cerebrum and cerebellum. The activity difference value (ADV) between 2 hemicerebrums was also calculated. Results: The TAC for [18F]O-FEt- PIB in the cerebrum or cerebellum peaked early (at approximately 2 min), but washed out a little slowly. In the dynamic and static micro-PET images, increased radioactivity was found in the area of the right HT in the model rats where infused with β-amyloid (1-40). No distinct difference of radioactivity was found between the right and left HT areas in the control rats. The ADV(HT) was approximately 14.6% in the AD model rats and approximately 4 times greater than that of the control rats (3.9%). Conclusion: To our knowledge, this study is the first to evaluate a small molecular PET probe for the p-amyloid deposits in vivo using micro-PET imaging in an AD-injected rat model. The suitable biological characters showed that the tracer had potential to be developed as a probe for detecting β-amyloid plaques in AD.

AB - Aim: To evaluate whether the newly-synthesized positron emission tomography (PET) tracer, [18F]2-(4′-(methylamino)phenyl)-6-fluoroethoxy- benzothiazole ([18F] O-FEt-PIB), could bind to β-amyloid aggregates in a rat model of Alzheimer's disease (AD) using micro-PET. Method: [18F]O-FEt-PIB was synthesized and purified by radio HPLC. PET imaging was performed with a R4 rodent model scanner in 3 model and 3 control rats. Dynamic PET scans were performed for 40 min in each rat following an injection of approximately 37 MBq of [18F]O-FEt-PIB. Static scans were also performed for 15 min in each rat. PET data were reconstructed by a maximum posteriori probability algorithm. On the coronal PET images, regions of interest were respectively placed on the cortex, hemicerebrum [including the hippocampus and thalamus (HT)], and were guided by a 3-D digital map of the rat brain or the brain images of [18F]2-Deoxy-2-fluoro-JD-glucose ([ 18F]FDG) in normal rats. Time-activity curves (TAC) were obtained for the cerebrum and cerebellum. The activity difference value (ADV) between 2 hemicerebrums was also calculated. Results: The TAC for [18F]O-FEt- PIB in the cerebrum or cerebellum peaked early (at approximately 2 min), but washed out a little slowly. In the dynamic and static micro-PET images, increased radioactivity was found in the area of the right HT in the model rats where infused with β-amyloid (1-40). No distinct difference of radioactivity was found between the right and left HT areas in the control rats. The ADV(HT) was approximately 14.6% in the AD model rats and approximately 4 times greater than that of the control rats (3.9%). Conclusion: To our knowledge, this study is the first to evaluate a small molecular PET probe for the p-amyloid deposits in vivo using micro-PET imaging in an AD-injected rat model. The suitable biological characters showed that the tracer had potential to be developed as a probe for detecting β-amyloid plaques in AD.

KW - [F]O-FEt-PIB

KW - Alzheimer's disease

KW - Micro-positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=42649139649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42649139649&partnerID=8YFLogxK

U2 - 10.1111/j.1745-7254.2008.00785.x

DO - 10.1111/j.1745-7254.2008.00785.x

M3 - Article

VL - 29

SP - 548

EP - 554

JO - Zhongguo yao li xue bao = Acta pharmacologica Sinica

JF - Zhongguo yao li xue bao = Acta pharmacologica Sinica

SN - 1671-4083

IS - 5

ER -